摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Phenoxysulfolan | 22167-75-5

中文名称
——
中文别名
——
英文名称
3-Phenoxysulfolan
英文别名
3-phenoxy-tetrahydro-thiophene-1,1-dioxide;3-Phenoxy-tetrahydro-thiophen-1,1-dioxid;3-Phenoxytetrahydrothiophene 1,1-dioxide;3-phenoxythiolane 1,1-dioxide
3-Phenoxysulfolan化学式
CAS
22167-75-5
化学式
C10H12O3S
mdl
MFCD00159106
分子量
212.269
InChiKey
LALZVUZOCGQJGE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    410.2±38.0 °C(Predicted)
  • 密度:
    1.288±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • INHIBITORS OF ERK NUCLEAR TRANSLOCATION
    申请人:Yeda Research and Development Co. Ltd.
    公开号:US20210292338A1
    公开(公告)日:2021-09-23
    Described herein are compounds having Formula I or Formula II: wherein each dashed line independently represents a saturated or unsaturated bond; R 1 and R′ 1 are aryl or heteroaryl as defined herein; and R 2 and R′ 2 are as defined herein. Further described is a method of inhibiting nuclear translocation of ERK1/2 in a cell, by contacting the cell with a compound having Formula I or Formula II. The compounds may also be for use in treating a disease or disorder associated with nuclear translocation of ERK1/2.
  • [EN] INHIBITORS OF ERK NUCLEAR TRANSLOCATION<br/>[FR] INHIBITEURS DE LA TRANSLOCATION NUCLÉAIRE D'ERK
    申请人:YEDA RES & DEV
    公开号:WO2020115744A1
    公开(公告)日:2020-06-11
    Described herein are compounds having Formula (I) or Formula (II): wherein each dashed line independently represents a saturated or unsaturated bond; R1 and R'1 are aryl or heteroaryl as defined herein; and R 2 and R' 2 are as defined herein. Further described is a method of inhibiting nuclear translocation of ERK1/2 in a cell, by contacting the cell with a compound having Formula (I) or Formula (II). The compounds may also be for use in treating a disease or disorder associated with nuclear translocation of ERK1/2.
  • DE682079
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多